Melissa Previtera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Melissa Previtera has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Adam de Havenon
Department of Neurology, Yale School of Medicine, New Haven, CT (A.d.H.).
1 shared publication - Akshitkumar M. Mistry
University of Louisville 5 Louisville
1 shared publication - Amit Bhattacharya
University of Cincinnati
1 shared publication - Andrew Timothy Trout
Department of Radiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA
1 shared publication - Anjanette Wells
School of Social Work College of Allied Health Sciences University of Cincinnati Cincinnati Ohio USA
1 shared publication - Carolyn Anne Chan
Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
1 shared publication
Latest Publications
- 29 September 2026
- Published by Wiley in Journal of Hospital Medicine
Clinical progress note: Management of the hospitalized patient with medetomidine withdrawal
Medetomidine is an ⍺2 adrenergic agonist that has rapidly emerged as an adulterant in the US illicit opioid supply. Clinicians should suspect medetomidine exposure when opioid overdoses respond poorly to naloxone. Medetomidine withdrawal is clinically distinct from opioid and xylazine withdrawal and should be suspected when a patient with opioid withdrawal presents with significant rebound sympathetic activation, including hypertension, tachycardia, tremor, agitation, and refractory vomiting despite opioid agonist treatment. Management requires concurrent treatment of opioid withdrawal, early use of ⍺2 agonists, and escalation to dexmedetomidine infusion for severe cases. Greater access to testing and prospective treatment data are needed.
- 29 September 2026
- Published by Wiley in Journal of Hospital Medicine
Clinical progress note: Management of the hospitalized patient with medetomidine withdrawal
Medetomidine is an ⍺2 adrenergic agonist that has rapidly emerged as an adulterant in the US illicit opioid supply. Clinicians should suspect medetomidine exposure when opioid overdoses respond poorly to naloxone. Medetomidine withdrawal is clinically distinct from opioid and xylazine withdrawal and should be suspected when a patient with opioid withdrawal presents with significant rebound sympathetic activation, including hypertension, tachycardia, tremor, agitation, and refractory vomiting despite opioid agonist treatment. Management requires concurrent treatment of opioid withdrawal, early use of ⍺2 agonists, and escalation to dexmedetomidine infusion for severe cases. Greater access to testing and prospective treatment data are needed.
- 1 October 2025
- Published by Journal of Graduate Medical Education in Journal of Graduate Medical Education
- Vol. 17 (5) , 579-594
Evaluating Methodology for Increasing Diversity in US Residency Training Programs: A Scoping Review
Background There remains limited understanding of effective strategies to increase diversity, equity, and inclusion within residency programs—highlighting the need for a comprehensive review of current interventions. Objective To synthesize literature regarding interventions to increase the representation of populations underrepresented in medicine (URiM) within US residency programs. Methods A scoping review of studies published from January 2000 to July 2023 was conducted. Data were extracted from PubMed, Embase, Cochrane Library, and Scopus. URiM was defined by race, ethnicity, and gender. Studies were included if an intervention was implemented by a graduate medical education residency program but were excluded if they did not describe a defined intervention or if they were published outside of the United States. Study interventions were categorized into 5 areas: applicant factors, selection measures, application screening, interviews, and post-interview communication. Results Initial search captured 2683 titles and abstracts; 257 full-text articles were reviewed, with 27 eligible articles meeting inclusion criteria. Eligible articles were categorized as: applicant–12 (44%), selection–8 (30%), screening–17 (63%), interview–8 (30%), and post-interview–4 (15%). Many articles addressed multiple interventions that positively impacted URiM composition, making it difficult to isolate the effect of individual interventions. Common, effective interventions included holistic reviews, clerkships, and standardized interviews. Conclusions This review demonstrates that interventions aimed at increasing diversity in residency programs vary in their approaches, but consistent evaluation and evidence of effectiveness are lacking from the current literature.
- 1 October 2025
- Published by Journal of Graduate Medical Education in Journal of Graduate Medical Education
- Vol. 17 (5) , 579-594
Evaluating Methodology for Increasing Diversity in US Residency Training Programs: A Scoping Review
Background There remains limited understanding of effective strategies to increase diversity, equity, and inclusion within residency programs—highlighting the need for a comprehensive review of current interventions. Objective To synthesize literature regarding interventions to increase the representation of populations underrepresented in medicine (URiM) within US residency programs. Methods A scoping review of studies published from January 2000 to July 2023 was conducted. Data were extracted from PubMed, Embase, Cochrane Library, and Scopus. URiM was defined by race, ethnicity, and gender. Studies were included if an intervention was implemented by a graduate medical education residency program but were excluded if they did not describe a defined intervention or if they were published outside of the United States. Study interventions were categorized into 5 areas: applicant factors, selection measures, application screening, interviews, and post-interview communication. Results Initial search captured 2683 titles and abstracts; 257 full-text articles were reviewed, with 27 eligible articles meeting inclusion criteria. Eligible articles were categorized as: applicant–12 (44%), selection–8 (30%), screening–17 (63%), interview–8 (30%), and post-interview–4 (15%). Many articles addressed multiple interventions that positively impacted URiM composition, making it difficult to isolate the effect of individual interventions. Common, effective interventions included holistic reviews, clerkships, and standardized interviews. Conclusions This review demonstrates that interventions aimed at increasing diversity in residency programs vary in their approaches, but consistent evaluation and evidence of effectiveness are lacking from the current literature.
- 19 June 2025
- Published by SAGE Publications in WORK: A Journal of Prevention, Assessment & Rehabilitation
- Vol. 82 (2) , 578-593
Work as a social determinant of health on cardiovascular and musculoskeletal diseases: A literature review
Background: Work, a social determinant of health (SDOH) can both affect and be affected by health. Objective: To examine literature related to work as a SDOH on cardiovascular and musculoskeletal disease among U.S. workers. Methods: A literature review was conducted. All studies investigating work-related SDOH on the following cardiovascular (stroke, hypertension) and musculoskeletal disease (arm and leg limbs, pain). Epigenetic influences were also evaluated, as it relates to these diseases. Results: The core concept of “work” as a SDOH on cardiovascular and musculoskeletal disease has yielded the “bio-ecological work” model, comprised of four main levels of influence: Work Environment, Interpersonal, Psychological, and Intrapersonal. The Work Environmental dimension includes: The health effects of unemployment and job insecurity, the impact of shift work schedules on health, balance between work effort and reward, the psychosocial work environment, the influence of control at work, demands, and decision latitude on worker's health, the link between health and the physical risks and hazards of work. The Interpersonal level consists of: The health implications of balancing work and family responsibilities and social support at work. The Psychological dimension includes perceived discrimination in the workplace and acute work-related stress and chronic disease. And the Intrapersonal level consists of workplace exposures on epigenetics, telomere length, and microRNA molecules. Conclusion: This work is important to inspire capacity building and research in occupational health, to prevent cardiovascular and musculoskeletal disorders in order to preserve a productive life for the ageing population.
- 19 June 2025
- Published by SAGE Publications in WORK: A Journal of Prevention, Assessment & Rehabilitation
- Vol. 82 (2) , 578-593
Work as a social determinant of health on cardiovascular and musculoskeletal diseases: A literature review
Background: Work, a social determinant of health (SDOH) can both affect and be affected by health. Objective: To examine literature related to work as a SDOH on cardiovascular and musculoskeletal disease among U.S. workers. Methods: A literature review was conducted. All studies investigating work-related SDOH on the following cardiovascular (stroke, hypertension) and musculoskeletal disease (arm and leg limbs, pain). Epigenetic influences were also evaluated, as it relates to these diseases. Results: The core concept of “work” as a SDOH on cardiovascular and musculoskeletal disease has yielded the “bio-ecological work” model, comprised of four main levels of influence: Work Environment, Interpersonal, Psychological, and Intrapersonal. The Work Environmental dimension includes: The health effects of unemployment and job insecurity, the impact of shift work schedules on health, balance between work effort and reward, the psychosocial work environment, the influence of control at work, demands, and decision latitude on worker's health, the link between health and the physical risks and hazards of work. The Interpersonal level consists of: The health implications of balancing work and family responsibilities and social support at work. The Psychological dimension includes perceived discrimination in the workplace and acute work-related stress and chronic disease. And the Intrapersonal level consists of workplace exposures on epigenetics, telomere length, and microRNA molecules. Conclusion: This work is important to inspire capacity building and research in occupational health, to prevent cardiovascular and musculoskeletal disorders in order to preserve a productive life for the ageing population.
- 6 March 2025
- Published by Elsevier in Academic Pediatrics
- Vol. 25 (4) , 102805
Exploring Shared Decision-Making Training in Pediatrics: A Scoping Review
- 6 March 2025
- Published by Elsevier in Academic Pediatrics
- Vol. 25 (4) , 102805
Exploring Shared Decision-Making Training in Pediatrics: A Scoping Review
- 18 October 2024
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 22 (2) , 172-182
A Scoping Review of Risk Presentation in Patient Decision Aids: Communicating Risk in Imaging
- 18 October 2024
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 22 (2) , 172-182
A Scoping Review of Risk Presentation in Patient Decision Aids: Communicating Risk in Imaging
- Open Access
- 20 February 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (4) , e031749
Asymptomatic Intracerebral Hemorrhage Following Endovascular Stroke Therapy Is Not Benign: A Systematic Review and Meta‐Analysis
Background: Asymptomatic intracerebral hemorrhage (aICH) occurs in approximately 35% of patients with acute ischemic stroke after endovascular thrombectomy. Unlike symptomatic ICH, studies evaluating the effect of aICH on outcomes have been inconclusive. We performed a systematic review and meta‐analysis to evaluate the long‐term effects of postendovascular thrombectomy aICH. Methods and Results: The meta‐analysis protocol was submitted to the International Prospective Register of Systematic Reviews a priori. PubMed, Scopus, and Web of Science were searched from inception through September 2023, yielding 312 studies. Two authors independently reviewed all abstracts. Included studies contained adult patients with ischemic stroke undergoing endovascular thrombectomy with follow‐up imaging assessment of ICH reporting comparative outcomes according to aICH versus no ICH. After screening, 60 papers were fully reviewed, and 10 studies fulfilled inclusion criteria (n=5723 patients total, 1932 with aICH). Meta‐analysis was performed using Cochrane RevMan v5.4. Effects were estimated by a random‐effects model to estimate summary odds ratio (OR) of the effect of aICH versus no ICH on primary outcomes of 90‐day modified Rankin Scale 3 to 6 and mortality. The presence of aICH was associated with a higher odds of 90‐day mRS 3 to 6 (OR, 2.17 [95% CI, 1.81–2.60], P I 2 46% Q 19.15) and mortality (OR, 1.72 [95% CI, 1.17–2.53], P :0.005, I 2 79% Q 27.59) compared with no ICH. This difference was maintained following subgroup analysis according to hemorrhage classification and recanalization status. Conclusions: The presence of aICH is associated with worse 90‐day functional outcomes and higher mortality. Further studies to evaluate the factors predicting aICH and treatments aimed at reducing its occurrence are warranted.
- 20 February 2024
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 13 (4) , e031749
Open AccessAsymptomatic Intracerebral Hemorrhage Following Endovascular Stroke Therapy Is Not Benign: A Systematic Review and Meta‐Analysis
Background: Asymptomatic intracerebral hemorrhage (aICH) occurs in approximately 35% of patients with acute ischemic stroke after endovascular thrombectomy. Unlike symptomatic ICH, studies evaluating the effect of aICH on outcomes have been inconclusive. We performed a systematic review and meta‐analysis to evaluate the long‐term effects of postendovascular thrombectomy aICH. Methods and Results: The meta‐analysis protocol was submitted to the International Prospective Register of Systematic Reviews a priori. PubMed, Scopus, and Web of Science were searched from inception through September 2023, yielding 312 studies. Two authors independently reviewed all abstracts. Included studies contained adult patients with ischemic stroke undergoing endovascular thrombectomy with follow‐up imaging assessment of ICH reporting comparative outcomes according to aICH versus no ICH. After screening, 60 papers were fully reviewed, and 10 studies fulfilled inclusion criteria (n=5723 patients total, 1932 with aICH). Meta‐analysis was performed using Cochrane RevMan v5.4. Effects were estimated by a random‐effects model to estimate summary odds ratio (OR) of the effect of aICH versus no ICH on primary outcomes of 90‐day modified Rankin Scale 3 to 6 and mortality. The presence of aICH was associated with a higher odds of 90‐day mRS 3 to 6 (OR, 2.17 [95% CI, 1.81–2.60], P I 2 46% Q 19.15) and mortality (OR, 1.72 [95% CI, 1.17–2.53], P :0.005, I 2 79% Q 27.59) compared with no ICH. This difference was maintained following subgroup analysis according to hemorrhage classification and recanalization status. Conclusions: The presence of aICH is associated with worse 90‐day functional outcomes and higher mortality. Further studies to evaluate the factors predicting aICH and treatments aimed at reducing its occurrence are warranted.